Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
78,888,889
-
Total 13F shares
-
57,466,718
-
Share change
-
-145,632
-
Total reported value
-
$326,999,436
-
Put/Call ratio
-
5.4%
-
Price per share
-
$5.69
-
Number of holders
-
115
-
Value change
-
-$1,731,457
-
Number of buys
-
64
-
Number of sells
-
47
Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q3 2022
As of 30 Sep 2022,
Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,466,718 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, EcoR1 Capital, LLC, FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, Cormorant Asset Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.